105 related articles for article (PubMed ID: 11038119)
1. Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization.
Molpeceres J; Aberturas MR; Guzman M
J Microencapsul; 2000; 17(5):599-614. PubMed ID: 11038119
[TBL] [Abstract][Full Text] [Related]
2. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
Saez A; Guzmán M; Molpeceres J; Aberturas MR
Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
[TBL] [Abstract][Full Text] [Related]
3. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
4. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres.
Aberturas MR; Molpeceres J; Guzmán M; García F
J Microencapsul; 2002; 19(1):61-72. PubMed ID: 11811760
[TBL] [Abstract][Full Text] [Related]
5. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
Chacón M; Molpeceres J; Berges L; Guzmán M; Aberturas MR
Eur J Pharm Sci; 1999 May; 8(2):99-107. PubMed ID: 10210732
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats].
Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N
Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.
Lai J; Lu Y; Yin Z; Hu F; Wu W
Int J Nanomedicine; 2010 Feb; 5():13-23. PubMed ID: 20161984
[TBL] [Abstract][Full Text] [Related]
9. Formation and characterization of cyclosporine-loaded nanoparticles.
Guzmán M; Molpeceres J; García F; Aberturas MR; Rodríguez M
J Pharm Sci; 1993 May; 82(5):498-502. PubMed ID: 8360826
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
Varela MC; Guzmán M; Molpeceres J; del Rosario Aberturas M; Rodríguez-Puyol D; Rodríguez-Puyol M
Eur J Pharm Sci; 2001 Feb; 12(4):471-8. PubMed ID: 11231114
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
[TBL] [Abstract][Full Text] [Related]
12. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A.
Calvo P; Sanchez A; Martinez J; Lopez MI; Calonge M; Pastor JC; Alonso MJ
Pharm Res; 1996 Feb; 13(2):311-5. PubMed ID: 8932455
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres.
Guzman M; Molpeceres J; Garcia F; Aberturas MR
J Microencapsul; 1996; 13(1):25-39. PubMed ID: 8903783
[TBL] [Abstract][Full Text] [Related]
14. Stability of cyclosporine-loaded poly-sigma-caprolactone nanoparticles.
Molpeceres J; Aberturas MR; Chacón M; Berges L; Guzmán M
J Microencapsul; 1997; 14(6):777-87. PubMed ID: 9394259
[TBL] [Abstract][Full Text] [Related]
15. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Dai W; Guo Y; Zhang H; Wang X; Zhang Q
Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562
[TBL] [Abstract][Full Text] [Related]
16. [Study on preparation conditions for polylactide nanoparticles loaded cyclosporine A and its oral bioavailability in rats].
Wang XQ; Zhang T; He Y; Zhang L; Zhang Q
Yao Xue Xue Bao; 2004 Jan; 39(1):68-71. PubMed ID: 15127586
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
Gref R; Quellec P; Sanchez A; Calvo P; Dellacherie E; Alonso MJ
Eur J Pharm Biopharm; 2001 Mar; 51(2):111-8. PubMed ID: 11226817
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A.
Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR
Drug Dev Ind Pharm; 2008 May; 34(5):492-8. PubMed ID: 18473231
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
20. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
